Results 171 to 180 of about 113,534 (285)
Rademikibart, a potent IL‐4Rα‐targeting antibody, achieved its primary endpoint as a treatment for adults with moderate‐to‐severe atopic dermatitis (AD) in the CBP‐201‐WW001 Phase 2 trial. There is a need for AD treatment options with convenient dosing intervals.
Jonathan I. Silverberg +2 more
wiley +1 more source
Hidden diversity of crust-like <i>Sebacinaceae</i> (<i>Sebacinales</i>, <i>Agaricomycetes</i>) in Asia. [PDF]
Suh H +6 more
europepmc +1 more source
ABSTRACT Immune‐checkpoint inhibitors (ICIs) have revolutionised melanoma treatment but can often cause severe and long‐standing cutaneous immune‐related adverse events (cirAEs). We report a case of refractory pembrolizumab‐induced pityriasis lichenoides (PL)‐like eruption successfully treated with dupilumab, leading to rapid and sustained remission ...
Evangelos Christou +2 more
wiley +1 more source
Preparation of <i>Astragalus membranaceus</i> Millet Rice Crust and Evaluation of Nutritional Components and Physicochemical Properties. [PDF]
Cui M +6 more
europepmc +1 more source
Effects of Different Afforestation Measures on Biological Soil Crust Properties and Microbial Communities in an Alpine Sandy Land. [PDF]
Du S +5 more
europepmc +1 more source
A geological carbon cycle sink hosted by ocean crust talus breccias. [PDF]
Coggon RM +17 more
europepmc +1 more source

